Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

982770

	registered interest
	date	08/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Young Offenders: Injuries
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of people identified as having an acquired brain injury on arrival living in the secure estate in each of the last five years.
	tabling member constituency	Rhondda
	tabling member printed	Chris Bryant
	uin	176034
	answer	answer is ministerial correction date of answer 11/10/2018 answer text <p>The information requested is not held centrally by the Department or NHS England.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 11/10/2018 11:51:46 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1446 label Biography information for Sir Chris Bryant

1054829

	registered interest
	date	04/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Yellow Fever: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will commission research into new vaccines for yellow fever in the event that Sanofi Pasteur does not undertake research into its yellow fever vaccine.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	216212
	answer	answer is ministerial correction date of answer 12/02/2019 answer text <p>The Department’s National Institute for Health Research (NIHR) welcomes funding applications for research into any aspect of human health, including the development of cheaper vaccines. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. In all disease areas, the amount of NIHR funding depends on the volume and quality of scientific activity.</p><p> </p><p>The NIHR and the Medical Research Council both have a wide portfolio of research activity in vaccines which cover clinical trials for new vaccines, new technologies, ways of improving uptake and cost effectiveness.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 12/02/2019 16:24:27 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1522 label Biography information for Adam Holloway

1150126

	registered interest
	date	16/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Women's Health Taskforce for England
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Answer of 7 March 2019 to Question 226643 on Women's Health Taskforce for England, on what dates the Women's Health Taskforce for England has met since February 2019; what the topics of discussion were at each meeting; whether the draft Terms of Reference for the Taskforce have been approved; and whether plans for information and involvement from (a) the Campaign Against Painful Hysteroscopy and (b) other campaign groups has been considered.
	tabling member constituency	West Ham
	tabling member printed	Lyn Brown
	uin	967
	answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>Since February 2019, the Taskforce has met on two further occasions on the following subjects:</p><p> </p><p>25 April 2019 on the menopause.</p><p>4 July 2019 on menstrual health.</p><p> </p><p>The draft Terms of Reference were revised after the Taskforce met on 31 January 2019, focusing on unplanned pregnancy. All of these meetings were held, and the draft Terms of Reference revised, when the Taskforce was co-chaired by the then Parliamentary Under Secretary for Mental Health, Inequalities and Suicide Prevention (Jackie Doyle-Price MP).</p><p> </p><p>The Taskforce has not worked directly with the campaign against painful hysteroscopies or other campaign groups. The Taskforce is co-chaired by the President the Royal College of Obstetricians and Gynaecologists.</p><p> </p><p>There are currently no plans to include outpatient hysteroscopy as an agenda item for a future meeting of the Women’s Health Taskforce; it is, of course, possible that the issue will be discussed under a different agenda item in the future.</p><p> </p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 968 question first answered 25/10/2019 11:02:11 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1583 label Biography information for Ms Lyn Brown

1128626

	registered interest
	date	23/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Whorlton Hall Hospital
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the average weekly fee per patient charged to the NHS was for the provision of care by Cygnet at Whorlton Hall.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	257682
	answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>This information is not held centrally.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 05/06/2019 14:03:55 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1439 label Biography information for Norman Lamb

983176

	registered interest
	date	08/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Wheelchairs: Procurement
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the contractual standards required by his Department are for the (a) issue and (b) renewal of private contracts with (a) Millbrook Healthcare and (b) other wheelchair providers.
	tabling member constituency	East Kilbride, Strathaven and Lesmahagow
	tabling member printed	Dr Lisa Cameron
	uin	176349
	answer	answer is ministerial correction date of answer 16/10/2018 answer text <p>This information is not held centrally. The majority of wheelchair services are commissioned locally by clinical commissioning groups.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 176350 question first answered 16/10/2018 11:03:21 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4412 label Biography information for Dr Lisa Cameron

997134

	registered interest
	date	29/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Wheelchairs: Procurement
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 October 2018 to Question 176349 on wheelchairs: procurement, if his Department will collate information on standards in private contracts between CCGs and wheelchairs providers.
	tabling member constituency	East Kilbride, Strathaven and Lesmahagow
	tabling member printed	Dr Lisa Cameron
	uin	184972
	answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>NHS England does not mandate service specifications for wheelchair services, but as part of its wheelchair improvement programme has developed a model service specification in collaboration with partners (and tested with clinical commissioning groups (CCGs) and wheelchair providers) which sets out the ambition for excellent wheelchair services and the specific elements CCGs need to consider when commissioning services. This was launched in July 2017.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 06/11/2018 16:26:04 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4412 label Biography information for Dr Lisa Cameron

1121891

	registered interest
	date	18/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Wheelchairs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of access to free wheelchairs for people with short-term mobility conditions or injuries.
	tabling member constituency	Coatbridge, Chryston and Bellshill
	tabling member printed	Hugh Gaffney
	uin	245941
	answer	answer is ministerial correction date of answer 30/04/2019 answer text <p>No recent assessment has been made of the provision of wheelchairs for short-term use.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 30/04/2019 09:58:49 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4614 label Biography information for Hugh Gaffney

923570

	registered interest
	date	13/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Vulnerable Adults
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many safeguarding adults reviews have been launched since 2010.
	tabling member constituency	Warwick and Leamington
	tabling member printed	Matt Western
	uin	153424
	answer	answer is ministerial correction date of answer 20/06/2018 answer text <p>For the year 2015-16 there were 90 Safeguarding Adult Reviews, the following year 2016-17 there were 110. The Department does not hold data for years prior to 2015, this was the first year data was recorded on Safeguarding Adult Reviews.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 20/06/2018 10:55:26 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4617 label Biography information for Matt Western

1105323

	registered interest
	date	26/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the 2019 voluntary scheme for branded medicines pricing and access affordability mechanism, whether his Department has conducted an impact assessment on the exemption of smaller companies from the rebate scheme.
	tabling member constituency	North Herefordshire
	tabling member printed	Bill Wiggin
	uin	237093
	answer	answer is ministerial correction date of answer 02/04/2019 answer text <p>The Department analysed the potential effects of the exemptions detailed in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access. However, this analysis did not take the form of a published impact assessment, as that formal process is not required for the voluntary agreement.</p><p> </p><p>The exemption from payments for small companies (sales under £5 million) was also part of the previous voluntary scheme; the 2014 Pharmaceutical Price Regulation Scheme. As such, the Department was already familiar with the scope of the small company exemption in advance of agreement on the 2019 Voluntary Scheme. The Department believes that the continuation of exemptions for small companies and the new approach to medium sized companies (£5 million to £25 million) is appropriate as it supports the growth of the life sciences industry through small and medium sized companies.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 02/04/2019 15:42:42 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1428 label Biography information for Sir Bill Wiggin

1105327

	registered interest
	date	26/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the 2019 voluntary scheme for branded medicines pricing and access affordability mechanism, whether his Department has conducted an impact assessment on how the 36-month exemption of new medicines from contributing to the rebate scheme will effect the NHS's drug procurement Bill.
	tabling member constituency	North Herefordshire
	tabling member printed	Bill Wiggin
	uin	237095
	answer	answer is ministerial correction date of answer 02/04/2019 answer text <p>The Department analysed the potential effects of the exemptions detailed in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access. However, this analysis did not take the form of a published impact assessment, as that formal process is not required for the voluntary agreement.</p><p> </p><p>In order to continue to support innovation and access to new medicines, the 2019 Voluntary Scheme includes a 36 month exemption from payments and freedom of pricing for new active substances (NAS). Under the previous 2014 Pharmaceutical Price Regulation Scheme that ended on 31 December 2018, NASs also had freedom of pricing and exemption from payments, but instead for the five year duration of that scheme. This means that under the 2019 Voluntary Scheme, payments will be received by the Department once that 36-month exemption has ended, sooner than under the previous Scheme, which will then be reinvested in the National Health Service.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 02/04/2019 15:41:50 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1428 label Biography information for Sir Bill Wiggin